Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 2
2016 2
2018 3
2019 4
2020 3
2021 3
2022 6
2023 7
2024 4
2025 12
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl AK, Rosenstock J, Rossing P, Vaduganathan M, Brinker M, Edfors R, Li N, Scheerer MF, Scott C, Nangaku M; CONFIDENCE Investigators. Agarwal R, et al. N Engl J Med. 2025 Aug 7;393(6):533-543. doi: 10.1056/NEJMoa2410659. Epub 2025 Jun 5. N Engl J Med. 2025. PMID: 40470996 Clinical Trial.
COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics.
Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl AK, Rosenstock J, Rossing P, Vaduganathan M, Brinker M, Edfors R, Li N, Scheerer MF, Scott C, Nangaku M; CONFIDENCE investigators. Agarwal R, et al. Nephrol Dial Transplant. 2025 Aug 1;40(8):1559-1569. doi: 10.1093/ndt/gfaf022. Nephrol Dial Transplant. 2025. PMID: 39916475 Free PMC article. Clinical Trial.
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy.
Lafayette R, Barbour SJ, Brenner RM, Campbell KN, Doan T, Eren N, Floege J, Jha V, Kim BS, Liew A, Maes B, Pal A, Pecoits-Filho R, Phoon RKS, Rizk DV, Suzuki H, Tesař V, Trimarchi H, Wei X, Zhang H, Barratt J; ORIGIN Phase 3 Trial Investigators. Lafayette R, et al. Among authors: pal a. N Engl J Med. 2026 Feb 12;394(7):647-657. doi: 10.1056/NEJMoa2510198. Epub 2025 Nov 6. N Engl J Med. 2026. PMID: 41196369 Clinical Trial.
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE.
Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl A, Osonoi T, Pal A, Rossing P, Rosenstock J, Vaduganathan M, Li L, Li N, Scott C, Manjrekar P, Yamashita S, Nangaku M. Agarwal R, et al. Among authors: pal a. Clin J Am Soc Nephrol. 2026 Jan 1;21(1):72-82. doi: 10.2215/CJN.0000000865. Epub 2025 Sep 18. Clin J Am Soc Nephrol. 2026. PMID: 40965042 No abstract available.
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both: Post Hoc Analyses of CONFIDENCE Trial.
Mottl A, Scott C, Green JB, Heerspink HJL, Mann JFE, McGill JB, Nangaku M, Rosenstock J, Rossing P, Li L, Li N, Vaduganathan M, Agarwal R; CONFIDENCE Trial Investigators. Mottl A, et al. J Am Soc Nephrol. 2026 Apr 1;37(4):764-776. doi: 10.1681/ASN.0000000928. Epub 2025 Nov 6. J Am Soc Nephrol. 2026. PMID: 41196655 Clinical Trial.
Study Design of a Nationwide Network Indian Cohort of Pregnancy-Associated Acute Kidney Injury (iPRAKI NET).
Meena P, Beniwal P, Pegu G, Singh S, Jhorawat R, Bhargava V, Thaniga D, Panda S, Suren S, Pal Singh P, Sirkanungo P, Rani K, Tiwari I, Rathore V, Kandari S, Pant P, Pal A, Mukherjee P, Verma H, Kute V, Fernando ME. Meena P, et al. Among authors: pal a. Kidney Int Rep. 2024 Dec 28;10(2):291-295. doi: 10.1016/j.ekir.2024.12.032. eCollection 2025 Feb. Kidney Int Rep. 2024. PMID: 39990896 Free PMC article. No abstract available.
A Review of the Role of Carcinoembryonic Antigen in Clinical Practice.
Hall C, Clarke L, Pal A, Buchwald P, Eglinton T, Wakeman C, Frizelle F. Hall C, et al. Among authors: pal a. Ann Coloproctol. 2019 Dec;35(6):294-305. doi: 10.3393/ac.2019.11.13. Epub 2019 Dec 31. Ann Coloproctol. 2019. PMID: 31937069 Free PMC article. Review.
44 results